RHOLISTIX

DEAD

Serial Number

88401759

Owner

Kadmon Pharmaceuticals, LLC

Attorney

Michael J. Leonard

Filing Date

Apr 25, 2019

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

RHOLISTIX Trademark

Serial Number: 88401759

RHOLISTIX is a trademark filed by Kadmon Pharmaceuticals, LLC on April 25, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Kadmon Pharmaceuticals, LLC (28 trademarks)

400 Madison Avenue
New York, NY 10017

Entity Type: 16

Legal Representation

Attorney of Record

Michael J. Leonard

4,109 trademarks filed View all →

Trademark Details

Filing Date

April 25, 2019

Registration Date

Not Registered

Published for Opposition

March 3, 2020

Goods & Services

Pharmaceuticals and pharmaceutical preparations, namely, Anti-infectives, anti-inflammatories, antibacterial pharmaceuticals, antibiotics, antifungal preparations, antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; pharmaceutical preparations and pharmaceutical agents for the treatment of Wilson's disease

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

May 30, 2023 MAB6

ABANDONMENT - NO USE STATEMENT FILED

May 29, 2023 ABN6

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 3, 2022 EXRA

SOU EXTENSION 5 GRANTED

Nov 2, 2022 EX5G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 2, 2022 AITU

SOU EXTENSION 5 FILED

Oct 25, 2022 EXT5

SOU TEAS EXTENSION RECEIVED

Oct 25, 2022 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 23, 2022 EXRA

SOU EXTENSION 4 GRANTED

Apr 21, 2022 EX4G

SOU EXTENSION 4 FILED

Apr 21, 2022 EXT4

SOU TEAS EXTENSION RECEIVED

Apr 21, 2022 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 23, 2021 EXRA

SOU EXTENSION 3 GRANTED

Oct 21, 2021 EX3G

SOU EXTENSION 3 FILED

Oct 21, 2021 EXT3

SOU TEAS EXTENSION RECEIVED

Oct 21, 2021 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 30, 2021 EXRA

SOU EXTENSION 2 GRANTED

Apr 28, 2021 EX2G

SOU EXTENSION 2 FILED

Apr 28, 2021 EXT2

SOU TEAS EXTENSION RECEIVED

Apr 28, 2021 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 30, 2020 EXRA

SOU EXTENSION 1 GRANTED

Oct 28, 2020 EX1G

SOU EXTENSION 1 FILED

Oct 28, 2020 EXT1

SOU TEAS EXTENSION RECEIVED

Oct 28, 2020 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Apr 28, 2020 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 3, 2020 NPUB

PUBLISHED FOR OPPOSITION

Mar 3, 2020 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Feb 12, 2020 NONP

ASSIGNED TO LIE

Jan 27, 2020 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Jan 24, 2020 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Jan 16, 2020 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jan 15, 2020 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 15, 2020 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jul 16, 2019 GNRN

NON-FINAL ACTION E-MAILED

Jul 16, 2019 GNRT

NON-FINAL ACTION WRITTEN

Jul 16, 2019 CNRT

ASSIGNED TO EXAMINER

Jul 8, 2019 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 10, 2019 NWOS

NEW APPLICATION ENTERED

Apr 29, 2019 NWAP

Related Trademarks

More from this Owner

IMMUNITAIRE

KADMONASSIST

RHOLISTIQ

More in Same Class